Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May 21;75(10):3240-50.
doi: 10.1021/jo1002054.

Structures, reactivities, and antibiotic properties of the marinopyrroles A-F

Affiliations

Structures, reactivities, and antibiotic properties of the marinopyrroles A-F

Chambers C Hughes et al. J Org Chem. .

Abstract

Cultivation of actinomycete strain CNQ-418, retrieved from a deep ocean sediment sample off the coast of La Jolla, CA, has provided marinopyrroles A-F. Sharing just 98% 16S rRNA gene sequence identity with S. sannurensis, the strain likely represents a new Streptomyces species. The metabolites contain an unusual 1,3'-bipyrrole core decorated with several chlorine and bromine substituents and possess marked antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). The congested N,C-biaryl bond establishes an axis of chirality that, for marinopyrroles A-E, is configurationally stable at room temperature. Moreover, the natural products are fashioned strictly in the M-configuration. The Paal-Knorr condensation was adapted for the synthesis of the 1,3'-bipyrrole core. Halogenation of this material with N-bromosuccinimide cleanly furnished the 4,4',5,5'-tetrahalogenated core that characterizes this class of marine-derived metabolites.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Partial NMR-based structure of marinopyrrole A (1)
Figure 2
Figure 2
ORTEP drawing of marinopyrrole F (6)
Scheme 1
Scheme 1
“Capping” the polar functionality in 1a a Reagents and conditions: (a) Ac2O, DMAP, pyr., rt, 62%; (b) Me2SO4, K2CO3, Me2CO, rt, quant.; (c) CH2N2, ether, 0 °C, 86%. DMAP = 4-(dimethylamino)pyridine
Scheme 2
Scheme 2
Nucleophilic aromatic substitution at C-5′a a Reagents and conditions: (a) K2CO3, MeOH, 65 °C, 42% (63% b.o.r.s.m); (b) N-acetylcysteamine, K2CO3, DMF, 80 °C, 55%; (c) NMe2, THF, 65 °C, 42%; (d) DMA, 145 °C, 62%; (e) NMe2, THF, 55 °C, quant. DMF = N,N-dimethylformamide, DMA = N,N-dimethylacetamide. b.o.r.s.m. = based on recovered starting material.
Scheme 3
Scheme 3
Imine formation at C-6
Scheme 4
Scheme 4
Proposed Ullman coupling for the synthesis of (±)-1
Scheme 5
Scheme 5
Synthesis of monodeoxypyoluteorin (10) and 3-halo analoguesa a Reagents and conditions: (a) aq. HCl, MeOH, rt, 83%; (b) NBS (1 equiv), DCE, 90 °C, 57%; (c) NIS, DCE, 90 °C, 65%; (d) NBS (2 equiv), DCE, 90 °C, 82%; (e) aq. HCl, MeOH, rt, 19: 94%, 20: 94%. NBS = N-bromosuccinimide, NIS = N-iodosuccinimide, DCE = 1,2-dichloroethane.
Scheme 6
Scheme 6
1H-chromeno[3,2-b]pyrrol-9-one 25 via intramolecular Ullman reaction
Scheme 7
Scheme 7
Synthesis of the tetrahalogenated 1,3′-bipyrrole core of the marinopyrrolesa a Reagents and conditions: (a) 1. 27, THF, −78 °C, 90%; 2. O3, −78 °C, then Me2S; (b) 29, THF, PTSA, 23% (two steps); (c) NBS, DCE, 90 °C, 86%. PTSA = p-toluenesulfonic acid, NBS = N-bromosuccinimide, DCE = 1,2-dichloroethane
Chart 1
Chart 1
Marinopyrroles A-F (1–6)
Chart 2
Chart 2
Axially chiral bipyrroles 7–9

References

    1. von Nussbaum F, Brands M, Hinzen B, Weigand S, Haebich D. Angew Chem, Int Ed. 2006;45:5072–5129. - PubMed
    2. Walsh C. Antibiotics: Actions, Origins, Resistance. ASM Press; Washington, D.C.: 2003.
    3. Schito GC. Clin Microbiol Infect. 2006;12:3–8. - PubMed
    4. Palavecino E. In: Methicillin-resistant Staphylococcus Aureus (MRSA) Protocols. Ji Y, editor. Humana Press; Totowa: 2007. pp. 1–19.
    1. Smith TL, Pearson ML, Wilcox KR, Cruz C, Lancaster MV, Robinson-Dunn B, Tenover FC, Zervos MJ, Band JD, White E, Jarvis WR. N Engl J Med. 1999;340:493–501. - PubMed
    1. Maldonado LA, Fenical W, Jensen PR, Kauffman CA, Mincer TJ, Ward AC, Bull AT, Goodfellow M. Int J Syst Evol Microbiol. 2005;55:1759–1766. - PubMed
    1. Fenical W, Jensen PR. Nat Chem Biol. 2006;2:666–673. - PubMed
    2. Hughes CC, MacMillan JB, Gaudêncio SP, Jensen PR, Fenical W. Angew Chem, Int Ed. 2009;48:725–727. - PMC - PubMed
    1. Hughes CC, Prieto-Davo A, Jensen PR, Fenical W. Org Lett. 2008;10:629–631. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources